Doseology Sciences Inc.
Doseology Sciences Inc., through its subsidiary, Dose Labs Inc., engages in the research, development, and sale of functional mushroom products with a focus on mental health research in Canada. The company also offers medicinal mushroom products, including tinctures. It sells its products online through doseology.com and e-commerce platforms, as well as through various retail chains and distribut… Read more
Doseology Sciences Inc. (DOSEF) - Total Liabilities
Latest total liabilities as of September 2025: $107.03K USD
Based on the latest financial reports, Doseology Sciences Inc. (DOSEF) has total liabilities worth $107.03K USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Doseology Sciences Inc. - Total Liabilities Trend (2020–2025)
This chart illustrates how Doseology Sciences Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Doseology Sciences Inc. Competitors by Total Liabilities
The table below lists competitors of Doseology Sciences Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Manila Broadcasting Co
PSE:MBC
|
Philippines | ₱1.20 Billion |
|
Select Sands Corp
PINK:SLSDF
|
USA | $14.52 Million |
|
Finsbury Growth & Income Trust
LSE:FGT
|
UK | GBX33.77 Million |
|
Huddled Group Plc
LSE:HUD
|
UK | GBX2.32 Million |
|
4 Less Group Inc
PINK:FLES
|
USA | $27.31 Million |
|
Ferronoux Holdings Inc
PSE:FERRO
|
Philippines | ₱14.23 Million |
|
Media Sentiment Inc
PINK:MSEZ
|
USA | $961.94K |
Liability Composition Analysis (2020–2025)
This chart breaks down Doseology Sciences Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 13.51 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.06 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Doseology Sciences Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Doseology Sciences Inc. (2020–2025)
The table below shows the annual total liabilities of Doseology Sciences Inc. from 2020 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | $94.11K | +14.08% |
| 2024-06-30 | $82.49K | -16.83% |
| 2023-06-30 | $99.19K | -88.62% |
| 2022-06-30 | $871.51K | -74.47% |
| 2021-06-30 | $3.41 Million | +3775.17% |
| 2020-06-30 | $88.09K | -- |